Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bee product could speed healing of diabetic foot sores

NCT ID NCT07509268

Disease control Sponsor: Universidad Autonoma de Nuevo Leon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a substance from royal jelly, called Royalactin, helps heal diabetic foot ulcers. Ten people with Wagner grade II ulcers received either Royalactin or a placebo applied to their wound three times a week for four weeks. Researchers measured wound size and looked at tissue samples to see how the ulcers were healing.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Royalactin (royal jelly extract)
What this could lead to
If it works, this could point toward a new way to help heal diabetic foot ulcers faster.
What could go wrong
This is a very small early-phase trial with only 10 people, so results may not apply widely. The treatment is applied topically and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

10 people

The number who actually took part.

Started

Sep 2022

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- Confirmed diagnosis of Diabetes Mellitus according to the 2020 ADA guidelines. * Stage II ulcer according to the Wagner classification for Diabetic Foot (deep ulcer, penetrating ligaments and muscles, without bone involvement or abscess formation). * Ulcer located on any area of the foot or ankle. * Ulcer with 80% granulation tissue. * Ankle-brachial index greater than 0.5 (not considered severe or critical arterial disease). * Negative stylet test. * Ability to attend wound care and follow-up appointments three times a week for four weeks. * Signed informed consent form. Exclusion Criteria: \- History of hypersensitivity reactions to dermatological products. * History of generalized dermatological pathology or pathology affecting the foot. * Diagnosis of autoimmune disease. * Local or systemic infection. * Hypersensitivity to any of the components of the experimental product.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic foot ulcer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Diabetic Foot

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetic foot ulcer

Contacts and locations

Locations

  • Facultad de medicina de la universidad autonoma de nuevo leon

    Monterrey, Nuevo León, 64460, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.